Philip McCarthy, MD is the director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute in Buffalo, New York. He has been in oncology practice for more than 20 years. His research interests include patient outcomes after blood and marrow transplantation, blood and marrow stem cell isolation, and preclinical models of bone marrow transplantation. He spoke with Oncology Data Advisor about when to consider bone marrow transplantation (BMT), barriers to transplant referrals, the improved safety of unrelated donor transplants, and the use of transplants in elderly patients.

Discussion Notes: On the types of transplants and when to consider this procedure [1:10] On the types of lymphoma that may benefit most from BMT [8:01] On the underutilization of BMT and why eligible patients may not receive transplant referrals [10:40] On how oncologists can address barriers to transplant referral [14:55] On the improved outcomes of unrelated donor transplants [16:48] On the use of BMT in elderly patients [21:48]